Physician profile
Sonia Yoo
NPI 1891710752
$37,285.79
in general payments reported to CMS, 2019-2025
31 companies · $7,267 in 2025
The $7,267 reported for 2025 was more than what 94% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,124 · 2020: $9,370 · 2021: $695 · 2022: $3,825 · 2023: $3,301 · 2024: $4,703 · 2025: $7,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,519 · Consulting Fee: $3,950 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,200 · Debt Forgiveness: $2,792 · Travel and Lodging: $775 · Gift: $36.07.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,518.76 |
| Consulting Fee | $3,950.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,200.00 |
| Debt Forgiveness | $2,791.54 |
| Travel and Lodging | $774.60 |
| Gift | $36.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $8,853.54 | 2019-2024 | Oxervate |
| Carl Zeiss Meditec, INC. | $6,564.23 | 2019-2025 | Visumax, Callisto Eye, Atlas 500 |
| Carl Zeiss Meditec USA, INC. | $3,801.68 | 2024-2025 | Cirrus Hd-Oct, Cirrus 6000 With Angioplex, Clarus |
| Oyster Point Pharma, INC. | $3,152.38 | 2022-2023 | Tyrvaya |
| Carl Zeiss Meditec Digital Innovations LLC | $2,791.54 | 2024 | Veracity Surgical |
| Johnson & Johnson Surgical Vision, INC. | $2,788.41 | 2019-2025 | Star S4 Ir, Ifs Advanced Femtosec Laser, Tecnis Iol |
| Alcon Vision LLC | $2,120.74 | 2019-2025 | Clareon, Centurion, Wavelight Ex500 Excimer Laser |
| Alcon Research LLC | $1,750.00 | 2020 | |
| Medical Microinstruments, INC. | $815.56 | 2024 | Symani Surgical Systems |
| Glaukos Corporation | $802.86 | 2020-2025 | Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Sun Pharmaceutical Industries INC. | $758.63 | 2019-2025 | Cequa |
| Bausch & Lomb Americas INC. | $605.92 | 2024-2025 | Miebo, Xiidra, Envista Envy Iol |
| Mallinckrodt Hospital Products INC. | $493.68 | 2020-2025 | Acthar |
| Ivantis, INC | $414.37 | 2019-2021 | |
| Abbvie INC. | $278.15 | 2024-2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $273.59 | 2019-2022 | |
| Biotissue Holdings INC. | $143.12 | 2022-2024 | |
| Kala Pharmaceuticals, INC. | $138.94 | 2022 | |
| Rxsight INC | $128.00 | 2022 | |
| Rayner Intraocular Lenses Limited | $124.99 | 2023 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Allergan, INC. | $110.74 | 2019 | |
| Mallinckrodt Enterprises LLC | $79.16 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $64.69 | 2024-2025 | Xdemvy |
| Resmed Corp | $60.74 | 2025 | |
| Johnson & Johnson Vision Care, INC. | $54.81 | 2023 | Mentor Siltex Round Spectrum |
| Staar Surgical Company | $39.00 | 2019 | |
| Baudax Bio INC. | $23.08 | 2022 | |
| Santen INC. | $20.91 | 2023 | Verkazia |
| Recordati_rare_diseases_inc. | $16.89 | 2023 | Cystadrops |
| Eyevance Pharmaceuticals LLC | $15.44 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonia Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.